RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,968 | -57.4% | 10,591 | -0.0% | 0.00% | -66.7% |
Q2 2023 | $11,651 | -7.6% | 10,592 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $12,604 | -20.1% | 10,592 | 0.0% | 0.00% | -25.0% |
Q4 2022 | $15,782 | -21.1% | 10,592 | -12.4% | 0.00% | -20.0% |
Q3 2022 | $20,000 | +100.0% | 12,096 | 0.0% | 0.01% | +150.0% |
Q2 2022 | $10,000 | -64.3% | 12,096 | -22.5% | 0.00% | -60.0% |
Q1 2022 | $28,000 | +3.7% | 15,608 | 0.0% | 0.01% | 0.0% |
Q4 2021 | $27,000 | -15.6% | 15,608 | 0.0% | 0.01% | -28.6% |
Q3 2021 | $32,000 | -11.1% | 15,608 | 0.0% | 0.01% | -12.5% |
Q2 2021 | $36,000 | – | 15,608 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Athyrium Capital Management, LP | 2,202,420 | $6,145,000 | 3.11% |
Samjo Capital LLC | 560,000 | $1,562,000 | 1.16% |
MAK CAPITAL ONE LLC | 1,224,264 | $3,416,000 | 0.81% |
Cowen Prime Services LLC | 470,500 | $1,313,000 | 0.50% |
Portolan Capital Management | 1,957,283 | $5,461,000 | 0.43% |
Parkman Healthcare Partners LLC | 601,967 | $1,679,000 | 0.39% |
Rubric Capital Management LP | 1,076,587 | $3,004,000 | 0.18% |
Frontier Wealth Management LLC | 49,112 | $2,142,000 | 0.16% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 466,992 | $1,303,000 | 0.16% |
AWM Investment Company, Inc. | 391,304 | $1,092,000 | 0.12% |